Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000929624-99-001067
Filing Date
1999-06-03
Accepted
1999-06-03 00:00:00
Documents
1
Group Members
ANSELM LEUNG ("LEUNG")BIOASIA INVESTMENTS, LLC ("BIOASIA")BIOASIA, LLC ("BA")BIOTECHNOLOGY DEVELOPMENT FUND III, L.P.COBLENTZ PATCH DUFFY & BASS LLP /FA/EDGAR ENGLEMAN ("ENGLEMAN")FRANK KUNG ("KUNG")

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 45420
  Complete submission text file 0000929624-99-001067.txt   47708
Mailing Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110
Business Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110 4089882500
CELTRIX PHARMACEUTICALS INC (Subject) CIK: 0000871395 (see all company filings)

EIN.: 943121462 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-41502 | Film No.: 99639475
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 KEARNY STREET 7TH FLOOR SAN FRANCISCO CA 94108-4510
Business Address 222 KEARNY STREET 7TH FLOOR SAN FRANCISCO CA 94108-4510
COBLENTZ PATCH DUFFY & BASS LLP /FA/ (Filed by) CIK: 0001087474 (see all company filings)